DE60123103D1 - Neue verbindungen - Google Patents

Neue verbindungen

Info

Publication number
DE60123103D1
DE60123103D1 DE60123103T DE60123103T DE60123103D1 DE 60123103 D1 DE60123103 D1 DE 60123103D1 DE 60123103 T DE60123103 T DE 60123103T DE 60123103 T DE60123103 T DE 60123103T DE 60123103 D1 DE60123103 D1 DE 60123103D1
Authority
DE
Germany
Prior art keywords
new connections
substituted
triazolo
pyrimidines
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60123103T
Other languages
English (en)
Other versions
DE60123103T2 (de
Inventor
Simon Guile
Barrie Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE60123103D1 publication Critical patent/DE60123103D1/de
Application granted granted Critical
Publication of DE60123103T2 publication Critical patent/DE60123103T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
DE60123103T 2000-11-09 2001-11-07 Neue verbindungen Expired - Fee Related DE60123103T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0004098 2000-11-09
SE0004098A SE0004098D0 (sv) 2000-11-09 2000-11-09 Novel compounds
PCT/SE2001/002472 WO2002038571A1 (en) 2000-11-09 2001-11-07 Novel compounds

Publications (2)

Publication Number Publication Date
DE60123103D1 true DE60123103D1 (de) 2006-10-26
DE60123103T2 DE60123103T2 (de) 2007-03-15

Family

ID=20281755

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60123103T Expired - Fee Related DE60123103T2 (de) 2000-11-09 2001-11-07 Neue verbindungen

Country Status (10)

Country Link
US (2) US6844348B2 (de)
EP (1) EP1335918B1 (de)
JP (1) JP4190282B2 (de)
AT (1) ATE339420T1 (de)
AU (1) AU2002212941A1 (de)
DE (1) DE60123103T2 (de)
ES (1) ES2271083T3 (de)
HK (1) HK1056361A1 (de)
SE (1) SE0004098D0 (de)
WO (1) WO2002038571A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004107A1 (en) * 2004-07-02 2006-01-05 Masanori Ojima Method for designing a pharmaceutical compound specific to a desired receptor, a designed compound thereby, and pharmaceutical compositions containing the same
DE102008002471A1 (de) * 2008-06-17 2009-12-24 Biotronik Vi Patent Ag Stent mit einer Beschichtung oder einem Grundkörper, der ein Lithiumsalz enthält, und Verwendung von Lithiumsalzen zur Restenoseprophylaxe
CN102653539B (zh) * 2011-03-01 2014-09-17 秦引林 一种抗血小板聚集化合物及其药物组合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR017014A1 (es) 1997-07-22 2001-08-22 Astrazeneca Ab Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos

Also Published As

Publication number Publication date
ATE339420T1 (de) 2006-10-15
US6844348B2 (en) 2005-01-18
HK1056361A1 (en) 2004-02-13
SE0004098D0 (sv) 2000-11-09
EP1335918A1 (de) 2003-08-20
JP4190282B2 (ja) 2008-12-03
US20050143399A1 (en) 2005-06-30
EP1335918B1 (de) 2006-09-13
US7345047B2 (en) 2008-03-18
JP2004513173A (ja) 2004-04-30
AU2002212941A1 (en) 2002-05-21
ES2271083T3 (es) 2007-04-16
WO2002038571A1 (en) 2002-05-16
DE60123103T2 (de) 2007-03-15
US20040029899A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
TR200000197T2 (tr) Yeni bileşimler
ATE216389T1 (de) Neue verbindungen
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
ATE403657T1 (de) Chemische verbindungen
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
CY1113047T1 (el) Νεα κρυσταλλικη και αμορφη μορφη μιας ενωσης τριαζολο (4,5-d) πυριμιδινης
WO2003095455A3 (en) Substituted pyrazolopyrimidines
WO2002048147A3 (en) Pyrazolopyridines
DE60212949D1 (de) Antivirale pyrazolopyridin verbindungen
TR200000152T2 (tr) Yeni bileşikler.
WO2004106293A3 (en) Oxazolyl - and thiazolyl - purine based tricyclic compounds.
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
WO2004075846A3 (en) Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
WO2005011609A3 (en) Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
ATE251162T1 (de) Triazolo(4,5-d)pyrimidin-verbindungen
DE60123103D1 (de) Neue verbindungen
ATE345343T1 (de) Triazolo(4,5-d)pyrimidinderivate als antithrombotische verbindungen
HRP20050790A2 (en) New combinations and new use of selected pharmaceutically active compounds
EP1436279A4 (de) Chemische verbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee